ClinicalTrials.gov Noncompliance By Industry Remains An FDA Concern

Despite “concerted” communications efforts by FDA, only 47% of clinical trials sponsored by industry are listed on registry website. Oncology Division Director Pazdur tells a House hearing that industry reluctance confuses the agency, which acknowledges “limited” enforcement capabilities.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet